SOO YOUN SONG

SOO YOUN SONG


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
SSSOO YOUN SONG
SOO YOUN SONG
YJYe Won Jung
Ye Won Jung
WSWonkyo Shin
Wonkyo Shin
MPMia Park
Mia Park
GLGeon Woo Lee
Geon Woo Lee
HYHeon Jong Yoo
Heon Jong Yoo
Endometriosis, which is the presence of endometrial stroma and glands outside the uterus, is one of the most frequently diagnosed gynecologic diseases in reproductive women. Patients with endometriosis suffer from various pain symptoms such as dysmenorrhea, dyspareunia, and chronic pelvic pain. The pathophysiology for chronic pain in patients with endometriosis has not been fully understood. Altered inflammatory responses have been shown to contribute to pain symptoms. Increased secretion of cytokines, angiogenic factors, and nerve growth factors has been suggested to increase pain. Also, altered distribution of nerve fibers may also contribute to chronic pain. Aside from local contributing factors, sensitization of the nervous system is also important in understanding persistent pain in endometriosis. Peripheral sensitization as well as central sensitization have been identified in patients with endometriosis. These sensitizations of the nervous system can also explain increased incidence of comorbidities related to pain such as irritable bowel disease, bladder pain syndrome, and vulvodynia in patients with endometriosis. In conclusion, there are various possible mechanisms behind pain in patients with endometriosis, and understanding these mechanisms can help clinicians understand the nature of the pain symptoms and decide on treatments for endometriosis-related pain symptoms.

26 January 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SHSukhwan Hyun
Sukhwan Hyun
JYJigeun Yoo
Jigeun Yoo
YJYewon Jung
Yewon Jung
WSWonkyo Shin
Wonkyo Shin
SSSOO YOUN SONG
SOO YOUN SONG
HYHeon Jong Yoo
Heon Jong Yoo
Background/Objectives: To compare the outcomes of single-port access laparoscopic surgery (SPALS) and single-site robotic surgery (SSRS) for benign gynecological diseases, we retrospectively analyzed clinical data from 367 patients who underwent gynecologic surgery at Sejong Chungnam National University Hospital from October 2020 to December 2023. Methods: Of these 367 patients, 197 underwent SPALS, whereas 170 underwent SSRS. The SPALS group comprised 87 patients who underwent hysterectomy; 107, adnexal surgery (cystectomy: 44, adnexectomy: 63); and 1 myomectomy. The SSRS group included 68 patients who underwent myomectomy; 61, adnexal surgery (cystectomy: 52, adnexectomy: 9); 35, hysterectomy, and 4, sacrocolpopexy. Results: Both surgical techniques were successful, with no patients requiring open surgery. No significant differences were observed in the baseline characteristics between the two groups. Compared with the SPALS group, the SSRS group had a younger age (39.8 ± 9.5 vs. 44.5 ± 12.3 years, p = 0.001). Severe intra-abdominal adhesions were more frequently observed in the SSRS group (p = 0.004). Operation time (118.1 ± 65.9 vs. 57.1 ± 27.3 min, p = 0.001), gas passing time (39.4 ± 15.37 vs. 30.4 ± 13.5 h, p = 0.001), and hospital length of stay (4.26 ± 1.02 vs. 4.02 ± 0.8 days, p = 0.012) were significantly longer in the SSRS group. However, no significant differences were found between the two groups in terms of intraoperative blood loss, intraoperative complications, or readmission rates. Conclusions: SSRS offers a feasible and promising approach for treating gynecological benign diseases. Younger and lower-parity patients tend to undergo SSRS rather than SPALS, with SSRS primarily performed for myomectomy and complex adnexal surgery. However, operation time and gas passing time were significantly longer in the SSRS group.

5 November 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
SSSOO YOUN SONG
SOO YOUN SONG
Polycystic ovary syndrome (PCOS) is the most common cause of anovulatory infertility, with ovulation induction remaining the first-line treatment approach. Although letrozole has emerged as the most effective monotherapy, treatment resistance, side effects, and patient preferences have led to increasing interest in adjunctive or alternative approaches. This narrative review summarizes the current evidence for ovulation induction in patients with PCOS, including conventional pharmacologic agents, such as clomiphene citrate, letrozole, gonadotropins, and insulin-sensitizing agents, as well as complementary therapies, such as acupuncture and Chinese herbal medicine. We also examine emerging adjuvants, such as vitamin D, omega-3 fatty acids, sildenafil, and antioxidants that may enhance clinical pregnancy rates or improve endometrial receptivity. While robust evidence supports the use of letrozole as a first-line agent, complementary and integrative therapies may offer additional benefits, particularly in treatment-resistant or preference-driven contexts. Further high-quality studies are needed to clarify the role of combined therapeutic strategies in optimizing fertility outcomes for women with PCOS.

28 October 2022 in Medicine
Verified
Journal Article
Open access
YJYe Won Jung
Ye Won Jung
SSSOO YOUN SONG
SOO YOUN SONG
WSWonkyo Shin
Wonkyo Shin
SCSu Min Chung
Su Min Chung
JPJi Won Park
Ji Won Park
HYHeon Jong Yoo
Heon Jong Yoo
The COVID 19 pandemic is far from over, and vaccines remain important tool for fighting the disease. As the preventive effects of the COVID-19 vaccine emerges, it is likely that the perception of importance and safety of vaccines have a positive effect on the acceptance of other vaccines. However, it is still unclear how COVID-19 pandemic has affected the general vaccination perception and acceptance. Therefore, the objective of this study was to investigate the impact of the COVID-19 pandemic on the perception of HPV vaccination. This study involved an offline survey of 161 women aged between 20 and 49 years who visited the gynecologic clinic at Chung-nam National University Sejong Hospital from January 2021 to June 2021. The questionnaire consists of items related to experience and knowledge of COVID-19 and HPV viruses, as well as attitudes toward HPV vaccination. Knowledge about COVID-19 virus and HPV correlated positively with their experiences (P = .011 and P = .045, respectively). Positive attitude was increased, and negative attitude was reduced toward HPV vaccination in the COVID-19 pandemic era. Participants stated that accurate information and cost reduction about HPV vaccine was needed to increase the HPV vaccination rate. During the COVID-19 pandemic era, positive attitudes towards HPV vaccination have tended to increase. To increase the HPV vaccination rate, public efforts are needed for further information and cost reduction.

5 August 2022 in Medicine
Verified
Journal Article
Open access
MPMia Park
Mia Park
MSMin Soon Song
Min Soon Song
BKByung Hun Kang
Byung Hun Kang
SSSOO YOUN SONG
SOO YOUN SONG
GLGeon Woo Lee
Geon Woo Lee
HYHeon Jong Yoo
Heon Jong Yoo
To evaluate the efficacy and safety of a gonadotropin-releasing hormone (GnRH) agonist for treating large-sized submucosal leiomyoma before hysteroscopic myomectomy. The data were retrospectively collected from patients who underwent a hysteroscopic myomectomy for a submucosal leiomyoma >3.5 cm in size from January 2009 to December 2018. The patients were divided into the GnRH group and the control group according to whether they were pretreated before surgery. A total of 61 patients were included in the study, 31 in the GnRH agonist group and 30 in the control group. At diagnosis, the maximum leiomyoma diameter was similar between the 2 groups (4.67 ± 0.6 cm in the GnRH agonist group vs 3.82 ± 0.6 cm in the control group, P = .061). After pretreatment with the GnRH agonist, the maximum diameter was significantly smaller in the GnRH agonist group compared to the control group (3.82 ± 0.6 vs 4.33 ± 0.8 cm, respectively, P = .004). The leiomyoma volume in the GnRH agonist group decreased by 55.6%, from 41.68 ± 15.7 to 23.19 ± 10.4 cm3, which led to significant differences in leiomyoma volume between the 2 groups (23.19 ± 10.4 cm3 in the GnRH agonist group vs 33.22 ± 24.7 cm3 in the control group, P = .042). The GnRH agonist group showed a shorter operation time (37.7 vs 43.9 minutes, P = .040) and less uterine distention media was used (6800 vs 9373.3 mL, P = .037) compared to the control group. Postoperative complications such as estimated blood loss, remnant leiomyoma, and recurrence were similar between the 2 groups. Treatment with a GnRH agonist before hysteroscopic myomectomy for large submucosal leiomyoma might decrease the volume of the leiomyoma, reduce operation time, and the amount of uterine-distension media used without surgical complications.

Verified
Journal Article
Open access
PDF file
SHSuk Hwan Hyun
Suk Hwan Hyun
BKByung Hun Kang
Byung Hun Kang
HKHae Ri Kim
Hae Ri Kim
YJYe Won Jung
Ye Won Jung
WSWonkyo Shin
Wonkyo Shin
HYHeon Jong Yoo
Heon Jong Yoo
Background: This study aimed to investigate the association of contrast extravasation (EV) detected on contrast-enhanced computed tomography (CE-CT) with the clinical characteristics, management, and outcomes of patients with postpartum hemorrhage (PPH). Methods: We retrospectively analyzed 51 patients with PPH who underwent CE-CT between August 2013 and July 2024. Patients were classified into EV (−) group (n = 28) and EV (+) group (n = 23). Baseline characteristics, management strategies, and clinical outcomes were compared. Results: The proportion of patients with a shock index (SI) ≥ 1.0 was significantly higher in the EV (+) group (10.7% vs. 39.1%, p = 0.017). Surgical intervention was more frequently required in the EV (+) group (10.7% vs. 56.5%, p = 0.001), whereas conservative management alone was more frequently successful in the EV (−) group (89.3% vs. 43.5%, p = 0.001). The EV (+) group showed higher rates of massive blood loss (> 2000 mL, 3.6% vs. 34.8%, p = 0.009), longer hospital stays (4.61 ± 2.61 vs. 6.88 ± 3.78 days, p = 0.034), and more frequent intensive care unit (ICU) admission (10.7% vs. 34.8%, p = 0.039). Patients in the EV (+) group had higher transfusion requirements (p < 0.005) and increased rates of disseminated intravascular coagulation (7.1% vs. 30.4%, p = 0.032). Conclusions: The presence of EV on CE-CT in PPH was associated with more severe clinical features, including greater transfusion requirements, increased rates of surgical intervention, ICU admission, and disseminated intravascular coagulation (DIC). Additionally, a higher proportion of patients with EV had a shock index ≥ 1.0, indicating early hemodynamic compromise.